| # | Drug | Count |
|---|---|---|
| 0 | OMALIZUMAB | 28 |
| 1 | PROPOFOL | 16 |
| 2 | CETIRIZINE HYDROCHLORIDE | 15 |
| 3 | PANTOPRAZOLE | 15 |
| 4 | ASPIRIN | 12 |
| 5 | ASPIRIN 325 MG | 12 |
| 6 | ASPIRIN 81 MG | 12 |
| 7 | LORAZEPAM | 12 |
| 8 | ALBUTEROL SULFATE | 11 |
| 9 | LEVOTHYROXINE SODIUM | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RUTIN | 1 | 0.0112 |
| 1 | HISTAMINE | 1 | 0.0069 |
| 2 | LETIBOTULINUMTOXINA-WLBG | 1 | 0.0034 |
| 3 | SUFENTANIL CITRATE | 2 | 0.0015 |
| 4 | DESFLURANE | 2 | 0.0012 |
| 5 | CONJUGATED ESTROGENS/BAZEDOXIFENE | 1 | 0.0011 |
| 6 | ISOFLURANE | 2 | 0.0010 |
| 7 | DEXCHLORPHENIRAMINE MALEATE | 1 | 0.0010 |
| 8 | NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE | 8 | 0.0009 |
| 9 | MEPIVACAINE HYDROCHLORIDE | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-IgE [EPC] | 28 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 28 |
| 2 | Benzodiazepine [EPC] | 25 |
| 3 | GLP-1 Receptor Agonist [EPC] | 18 |
| 4 | General Anesthetic [EPC] | 18 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 12 |
| 6 | Corticosteroid [EPC] | 11 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 9 |
| 8 | Histamine-2 Receptor Antagonist [EPC] | 9 |
| 9 | Opioid Agonist [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | General Anesthetic [EPC] | 18 | 0.0004 |
| 1 | Anti-IgE [EPC] | 28 | 0.0003 |
| 2 | Antiseptic [EPC] | 1 | 0.0002 |
| 3 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Leukotriene Receptor Antagonist [EPC] | 3 | 0.0001 |
| 5 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 6 | Amide Local Anesthetic [EPC] | 7 | 0.0001 |
| 7 | Radiographic Contrast Agent [EPC] | 2 | 0.0001 |
| 8 | Histamine-2 Receptor Antagonist [EPC] | 9 | 0.0001 |
| 9 | Ester Local Anesthetic [EPC] | 3 | 0.0001 |